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Abstract
We report here one new, hospitalized case of Anaplasma
phagocytophilum in Belgium. The clinical presentation of anaplas-
mosis, its treatment and the molecular and serological relevant
laboratory methods are briefly developed.
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Human granulocytic anaplasmosis (HGA) is caused by the
obligate intracellular bacterium Anaplasma phagocytophilum,
which parasitizes neutrophilic granulocytes in mammalian
hosts. This pathogen is transmitted by the bite of infected
ticks of the family of Ixodidae. In Belgium a recent study
detected A. phagocytophilum by PCR in 14% of the examined
Ixodes ricinus ticks [1]. The incubation period following the
infecting tick bite is 5–21 days. Most patients have mild flu-like
clinical signs but infection can result in hospitalization and
severe complications have been described [2,3]. The number
of PCR-confirmed laboratory cases in Belgium and its neigh-
bour countries France, Germany and the Netherlands is low,
fewer than ten in the last 10 years [4–8].
A 60-year-old man without special medical history was seen
by his general practitioner (GP) on 26 August 2013 with a
fever of 40.5°C, chills, myalgia, arthralgia and severe headache
of 3-day duration.
The patient noted the presence of a yellow-blue coloured
bump in the groin area, possibly due to a tick bite, one week
before symptom onset, while on holiday in the Ardennes, a
forested region 100 km east of Brussels, the Belgian capital.
Initial laboratory results showed leucopenia (3.04 9 109/L -
reference values (rv) 4 9 109 to 10 9 109/L) with lymphocy-
topenia (8.9%), thrombocytopenia (93 9 109/L; rv 150 9 109
to 450 9 109/L), moderately increased levels of transaminases
(aspartate aminotransferase 46 U/L; rv <37 U/L; alanine ami-
notransferase 47 U/L; rv <40 U/L), lactate dehydrogenase
(223 U/L; rv <193 U/L), and an increased level of C-reactive
protein (131 mg/L; rv <5 mg/L) (Table 1).
As a result of the symptoms and the abnormal laboratory
results, the GP referred this patient the same evening to the
Emergency Department of a nearby Belgian hospital. The
clinical examination showed no skin rash and no nausea.
All blood and cerebrospinal fluid (CSF) cultures were
unrevealing and specific serological tests were negative. Blood
and CSF samples were negative for antibodies to Borrelia spp.
Serologies for hantaviruses, Epstein–Barr virus, cytomegalovi-
rus, parvovirus and leptospires were also negative.
The patient was treated with ceftriaxone without amelio-
ration of symptoms, with even an aggravation of his throm-










msp2 IgM (IFA) IgG (IFA)
3 NF Pos <1:20 <1:64
6 NF Pos <1:20 <1:64
12 ND Pos 1:2560 1:128
19 ND Neg 1:640 1:256
26 ND Neg 1:640 1:1024
33 ND Neg 1:320 1:512
39 ND ND 1:80 1:256
47 ND ND 1:40 1:256
54 ND ND 1:20 1:256
61 ND ND <1:20 1:256
89 ND ND <1:20 1:256
NF, not found of morulae within neutrophils cells; ND, not done; Pos, positive; Neg,
negative; IFA, immunofluorescence assay; IgM <1/20, negative; IgG <1/64, negative.
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bocytopenia (37 9 109/L; nl 150 9 109 to 450 9 109/L) on
the fourth day of hospitalization. On the fifth day, addition of
minocycline (100 mg twice a day for 1 week) resulted within
48 h in rapid improvement and recovery.
The Belgian National Reference Center for Anaplasma
received serum and EDTA samples taken on 26 August and
serum samples taken during the hospitalization. This reference
laboratory is partially supported by the Belgian Ministry of
Social Affairs through a fund within the Health Insurance System
[9] and disposes of different diagnostic tools to confirm the
diagnosis of anaplasmosis. The direct methods aim at visualizing
the bacteria by microscopic detection of the characteristic
intracytoplasmic inclusions (morulae) in the neutrophilic gran-
ulocytes and detecting specific nucleic acid sequences by
real-time PCR. The indirect method detects the antibodies
elicited by the infection by using an immunofluorescence assay
(Focus Diagnostics, Cypress, CA, USA). This serology provides
a retrospective diagnosis as IgM and IgG antibodies are not
usually present during the early phase of the disease.
The microscopic examination of blood smears stained with
May–Gr€unwald–Giemsa was negative.
The real-time PCR performed according to Courtney et al.
[10] and targeting the msp2 Anaplasma gene detected the
presence of A. phagocytophilum DNA in the acute phase (3rd
day after the onset of symptoms) and was still positive on the
12th day. These two PCR-positive samples were subjected to
an additional conventional PCR, targeting the groEL gene
followed by DNA sequencing [11]. Both samples yielded
identical DNA sequences of 559 bp, which were 100% similar
to four A. phagocytophilum isolates from GenBank. Two
isolates from Cervus elaphus came from Spain (HM057223,
HM057225) and two were from I. ricinus from Poland and
Slovakia (KF312360, KF383239). Moreover, the sample from
the 3rd day after the onset of symptoms was tested for
A. phagocytophilum by using a conventional PCR assay that
amplified a portion of the 16S rRNA gene followed by DNA
sequencing. The primer pair used for both amplification and
sequencing was 536F (50-CAGCAGCCGCGGTAATAC-30)
and rp2 (50-ACGGCTACCTTGTTACGACTT-30). The PCR
product was 987 bp, as expected, and its sequence was 99.6%
identical to the 16S rRNA sequences from A. phagocytophilum
strains Dog2 (CP006618), HZ (CP000235), HZ2 (CP006616),
JM (CP006617), NE-16S-1 (JN990105), HB-SZ-HGA-S04
(HQ872464) and USG3 (AY055469). The obtained 16S rRNA
sequence was deposited in GenBank under accession number
KM 259921. All these findings unequivocally confirm the
presence of A. phagocytophilum DNA in the patient samples.
The IgM antibodies to A. phagocytophilum peaked at the 12th
day after onset of symptoms, the IgG antibodies peaked at the
26th day (Table 1). This seroconversion with a fourfold rise in
antibody titres, the PCR results and the epidemiological,
clinical and biological criteria all confirm the diagnosis of HGA
[2,12,13]. We acknowledge the fact that as the majority of
serological tests can still be negative early in the disease and no
follow-up samples were examined for these pathogens,
simultaneous infections with one of the other tested patho-
gens and A. phagocytophilum cannot be excluded.
In conclusion, we report a new case of human anaplasmosis
in Belgium. This case highlights the importance of combining
clinical suspicion with correct timely laboratory workup to
diagnose and adequately treat a disease which is, at least in




1. Claerebout E, Losson B, Cochez C et al. Ticks and associated
pathogens collected from dogs and cats in Belgium. Parasit Vectors
2013; 6: 183.
2. Bakken JS, Dumler JS. Clinical diagnosis and treatment of human
granulocytotrophic anaplasmosis. Ann N Y Acad Sci 2006; 1078: 236–247.
3. Dumler JS. The biological basis of severe outcomes in Anaplasma
phagocytophilum infection. FEMS Immunol Med Microbiol 2012; 64:
13–20.
4. Edouard S, Koebel C, Goehringer F et al. Emergence of human
granulocytic anaplasmosis in France.Ticks Tick BorneDis2012; 3: 402–404.
5. Cochez C, Ducoffre G, Vandenvelde C, Luyasu V, Heyman P.
Anaplasmosis in Belgian: a ten-year sero-surveillance. Ticks Tick Borne
Dis 2011; 2: 156–159.
6. Van Dobbenburgh A, Van Dam AP, Fikrig E. Human granulocytic
ehrlichiosis in Western Europe. N Engl J Med 1999; 340: 1214–1216.
7. Pierard D, Levtchenko E, Dawson JE, Lauwers S. Ehrlichiosis in
Belgium. Lancet 1995; 346: 1233–1234.
8. Hagedorn P, Imhoff M, Fischer C, Domingo C, Niedrig M. Human
granulocytic anaplasmosis acquired in Scotland, 2013. Emerg Infect Dis
2014; 20: 1079–1081.
9. Muyldermans G, Litzroth A, Ducoffre G, Quoilin S; Medical-Technical
Advisory Board. Establishment and reinforcement of the national
reference centers for human microbiology in Belgium. Arch Public
Health 2012; 70: 16.
10. Courtney JW, Kostelnik LM, Zeidner NS, Massung RF. Multiplex
real-time PCR for detection of Anaplasma phagocytophilum and Borrelia
burgdorferi. J Clin Microbiol 2004; 42: 3164–3168.
11. Alberti A, Zobba R, Chessa B et al. Equine and canine Anaplasma
phagocytophilum strains isolated on the island of Sardinia (Italy) are
phylogenetically related to pathogenic strains from the United States.
Appl Environ Microbiol 2005; 71: 6418–6422.
12. Brouqui P, Bacellar F, Baranton G et al. Guidelines for the diagnosis of
tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004; 10:
1108–1132.
13. Centers for Disease Control and Prevention. Case definitions for
infectious conditions under public health surveillance. MMWR Recomm
Rep 1997; 46(RR-10): 1–55.
ª 2014 The Authors. New Microbes and New Infections published by John Wiley & Sons Ltd on behalf of the European Society of Clinical Microbiology and Infectious Disease., NMNI, 2, 177–178
178 New Microbes and New Infections, Volume 2 Number 6, November 2014 NMNI
Open access under CC BY license.
